Line separator


Gene Differences Could Have Black Patients Undergoing Unnecessary Biopsies

WEDNESDAY, June 30, 2021 (HealthDay News) — A gene variant may be driving high rates of unnecessary bone marrow biopsies in Black Americans, researchers say.

The variant is responsible for lower white blood cell levels in some healthy Black people, the investigators said.

“We’ve essentially created this racial health disparity by not fully considering how genetic variation affects white blood cell levels,” said study co-author Dr. Jonathan Mosley, assistant professor of medicine and biomedical informatics at Vanderbilt University Medical Center in Nashville, Tenn. “Our study supports genotyping African Americans before performing a bone marrow biopsy for the indication of isolated low white blood cell counts.”

The researchers analyzed data on 399 Black patients under age 90 who had bone marrow biopsies at three U.S. medical centers between 1998 and 2020.

Of those, 35 (9%) underwent a bone marrow biopsy due to low white blood cell counts. And 34 of those 35 (97%) had the gene variant that causes lower white cell counts. That compared to 67% of patients who had bone marrow biopsies for other reasons.

The biopsies were normal for 97% of patients with the gene variant, compared to 55% of those who had biopsies for other reasons, according to findings published June 28 in the journal JAMA Internal Medicine.

About 63% of Black Americans carry two copies of the gene variant, according to the researchers.

Mosley noted that the definition of a “normal” range for white blood cell count is based largely on averages from people of European ancestry.

“Genetic variation has a large impact on the levels of biomarkers like white blood cell counts, but reference ranges are defined based on population averages without taking genotypes into account,” Moseley said in a hospital news release.

Read more here: